Study Assessing the Efficacy and Safety of STN1013600 Ophthalmic Solution 0.1% and 0.3% Compared With Placebo in Subjects With Presbyopia

NCT05665387 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

79

Enrollment

INDUSTRY

Sponsor class

Conditions

Presbyopia

Interventions

DRUG: 0.1% STN1013600 ophthalmic solution
DRUG: 0.3% STN1013600 ophthalmic solution
DRUG: Placebo

Sponsor

Santen Inc.